当前位置:首页 - 行情中心 - 药康生物(688046) - 财务分析

药康生物

(688046)

  

流通市值:83.48亿  总市值:83.48亿
流通股本:4.10亿   总股本:4.10亿

药康生物(688046)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.47亿元,每股收益0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益227888.47万元,未分配利润55774.83万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产286803.81万元,负债58915.34万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入208,076,700793,389,024.92575,576,818.48374,808,989.09
营业总成本156,814,985.14624,226,092.52446,747,545.25287,113,871.94
其他经营收益
营业利润53,555,759.19165,118,101.96120,290,164.3877,525,168.73
利润总额53,555,015.6164,922,208.16120,160,805.7977,442,220.69
净利润47,103,795.92142,636,806.31109,900,074.670,905,477.14
每股收益
其他综合收益1,472,862.18-1,566,598.08-471,982.53-555,105.94
综合收益总额48,576,658.1141,070,208.23109,428,092.0670,350,371.2
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,711,353,086.171,751,473,680.521,791,318,747.031,781,760,715.63
非流动资产:
非流动资产合计1,156,685,043.761,113,593,130.951,038,737,191.681,016,729,686.4
资产总计2,868,038,129.932,865,066,811.472,830,055,938.712,798,490,402.03
流动负债:
流动负债合计477,623,308.75527,144,152.75542,562,949.01543,757,965.56
非流动负债:
非流动负债合计111,530,123.51110,725,505.1586,446,661.1686,820,268.08
负债合计589,153,432.26637,869,657.9629,009,610.17630,578,233.64
所有者权益(或股东权益):
归属于母公司股东权益合计2,278,884,697.672,227,197,153.572,201,046,328.542,167,912,168.39
股东权益合计2,278,884,697.672,227,197,153.572,201,046,328.542,167,912,168.39
负债和股东权益合计2,868,038,129.932,865,066,811.472,830,055,938.712,798,490,402.03
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计176,656,119.21845,227,504.87532,286,911.78317,753,772.45
经营活动现金流出小计180,746,032.95618,200,507.82445,112,587.11302,488,793.84
经营活动产生的现金流量净额-4,089,913.74227,026,997.0587,174,324.6715,264,978.61
投资活动产生的现金流量:
投资活动现金流入小计939,952,273.222,566,710,815.811,745,964,074.19919,466,872.79
投资活动现金流出小计969,692,800.553,033,291,033.512,339,423,327.691,266,130,881.5
投资活动产生的现金流量净额-29,740,527.33-466,580,217.7-593,459,253.5-346,664,008.71
筹资活动产生的现金流量:
筹资活动现金流入小计29,210,000313,015,082.88266,418,263.99231,699,600
筹资活动现金流出小计62,456,549.44286,121,363.21157,111,764.7381,276,424.52
筹资活动产生的现金流量净额-33,246,549.4426,893,719.67109,306,499.26150,423,175.48
汇率变动对现金及现金等价物的影响-4,357,164.26-2,614,681.6754,614.881,744,503.74
现金及现金等价物净增加额-71,434,154.77-215,274,182.65-396,923,814.7-179,231,350.88
期末现金及现金等价物余额414,478,083.73485,941,260.08304,291,628.03521,984,091.85
补充资料:
现金及现金等价物的净增加额--215,274,182.65--179,231,350.88
最新报告期:2026-04-28
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
信达证券唐爱金0.460.580.702026-04-28
国信证券彭思宇,陈曦炳,马千里0.450.580.602026-04-27
华泰证券代雯,袁中平,陈睿恬0.470.580.702026-04-23
中邮证券徐智敏,盛丽华0.420.49--2026-03-20
国泰海通周航,余文心0.430.50--2026-03-13
TOP↑